Works matching DE "EFAVIRENZ-emtricitabine-tenofovir (Drug)"

Results: 81
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14

    Atazanavir Plus Ritonavir or Efavirenz as Part of a 3-Drug Regimen for Initial Treatment of HIV-1.

    Published in:
    Annals of Internal Medicine, 2011, v. 154, n. 7, p. 445, doi. 10.7326/0003-4819-154-7-201104050-00316
    By:
    • Eric S. Daar, MD; Camlin Tierney, PhD; Margaret A. Fischl, MD; Paul E. Sax, MD; Katie Mollan, MS; Chakra Budhathoki, PhD;;
    • Godfrey, Catherine;
    • Jahed, Nasreen C.;
    • Myers, Laurie;
    • Katzenstein, David;
    • Farajallah, Awny;
    • Rooney, James F.;
    • Pappa, Keith A.;
    • Woodward, William C.;
    • Patterson, Kristine;
    • Bolivar, Hector;
    • Benson, Constance A.;
    • Collier, Ann C.
    Publication type:
    Article
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25

    Patient-reported outcomes in the single-tablet regimen (STaR) trial of rilpivirine/emtricitabine/tenofovir disoproxil fumarate versus efavirenz/emtricitabine/tenofovir disoproxil fumarate in antiretroviral treatment-naive adults infected with HIV-1 through 48 weeks of treatment

    Published in:
    AIDS Care, 2016, v. 28, n. 3, p. 401, doi. 10.1080/09540121.2015.1096890
    By:
    • Wilkins, Ed L.;
    • Cohen, Calvin J.;
    • Trottier, Benoit;
    • Esser, Stefan;
    • Smith, Don E.;
    • Haas, Bernhard;
    • Brinson, Cynthia;
    • Garner, Will;
    • Chuck, Susan;
    • Thorpe, David;
    • De-Oertel, Shampa
    Publication type:
    Article
    26
    27

    Adherence to Antiretroviral Therapy During and After Pregnancy: Cohort Study on Women Receiving Care in Malawi's Option B+ Program.

    Published in:
    Clinical Infectious Diseases, 2016, v. 63, n. 9, p. 1227, doi. 10.1093/cid/ciw500
    By:
    • Haas, Andreas D.;
    • Msukwa, Malango T.;
    • Egger, Matthias;
    • Tenthani, Lyson;
    • Tweya, Hannock;
    • Jahn, Andreas;
    • Gadabu, Oliver J.;
    • Tal, Kali;
    • Salazar-Vizcaya, Luisa;
    • Estill, Janne;
    • Spoerri, Adrian;
    • Phiri, Nozgechi;
    • Chimbwandira, Frank;
    • van Oosterhout, Joep J.;
    • Keiser, Olivia
    Publication type:
    Article
    28

    Long-term Treatment With Raltegravir or Efavirenz Combined With Tenofovir/ Emtricitabine for Treatment-Naive Human Immunodeficiency Virus-1-Infected Patients: 156-Week Results From STARTMRK.

    Published in:
    Clinical Infectious Diseases, 2011, v. 53, n. 8, p. 807, doi. 10.1093/cid/cir510
    By:
    • 6Rockstroh, Jürgen K.;
    • Lennox, Jeffrey L.;
    • De Jesus, Edwin;
    • Saag, Michael S.;
    • Lazzarin, Adriano;
    • Wan, Hong;
    • Walker, Monica L.;
    • Xu, Xia;
    • Zhao, Jing;
    • Teppler, Hedy;
    • DiNubile, Mark J.;
    • Rodgers, Anthony J.;
    • Nguyen, Bach-Yen;
    • Leavitt, Randi;
    • Sklar, Peter
    Publication type:
    Article
    29

    Rilpivirine Versus Efavirenz with Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment-Naïve HIV-1-Infected Patients with HIV-1 RNA ≤100,000 Copies/mL: Week 96 Pooled ECHO/THRIVE Subanalysis.

    Published in:
    AIDS Patient Care & STDs, 2014, v. 28, n. 4, p. 168, doi. 10.1089/apc.2013.0310
    By:
    • Behrens, Georg;
    • Rijnders, Bart;
    • Nelson, Mark;
    • Orkin, Chloe;
    • Cohen, Calvin;
    • Mills, Anthony;
    • Elion, Richard A.;
    • Vanveggel, Simon;
    • Stevens, Marita;
    • Rimsky, Laurence;
    • Thorpe, David;
    • Bosse, Matthew;
    • White, Kirsten;
    • Zhong, Lijie;
    • DeMorin, Jennifer;
    • Chuck, Susan K.
    Publication type:
    Article
    30
    31
    32
    33
    34

    Trend over time of HIV‐1 drug resistance to nonnucleoside reverse transcriptase inhibitors (NNRTIs) and their drivers: A cohort study from Antiviral Response Cohort Analysis (ARCA).

    Published in:
    HIV Medicine, 2023, v. 24, n. 11, p. 1150, doi. 10.1111/hiv.13525
    By:
    • Rancan, Ilaria;
    • Cassol, Chiara;
    • Graziani, Lucia;
    • Tilli, Marta;
    • Malcontenti, Costanza;
    • Russo, Chiara;
    • Bottanelli, Martina;
    • Bracchitta, Fiorenza;
    • Papaioannu, Rebecka;
    • Labate, Laura;
    • Mora, Sara;
    • Bezenchek, Antonia;
    • Shallvari, Adrian;
    • Di Biagio, Antonio;
    • Rossetti, Barbara
    Publication type:
    Article
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47

    Cytochrome P450 2B6 (CYP2B6) and constitutive androstane receptor (CAR) polymorphisms are associated with early discontinuation of efavirenz-containing regimens.

    Published in:
    Journal of Antimicrobial Chemotherapy (JAC), 2011, v. 66, n. 9, p. 2092
    By:
    • Wyen, Christoph;
    • Hendra, Heidy;
    • Siccardi, Marco;
    • Platten, Martin;
    • Jaeger, Hans;
    • Harrer, Thomas;
    • Esser, Stefan;
    • Bogner, Johannes R.;
    • Brockmeyer, Norbert H.;
    • Bieniek, Bernhard;
    • Rockstroh, Juergen;
    • Hoffmann, Christian;
    • Stoehr, Albrecht;
    • Michalik, Claudia;
    • Dlugay, Verena;
    • Jetter, Alexander;
    • Knechten, Heribert;
    • Klinker, Hartwig;
    • Skaletz-Rorowski, Adriane;
    • Fätkenheuer, Gerd
    Publication type:
    Article
    48
    49

    Four year follow-up of simplification therapy with once-daily emtricitabine, didanosine and efavirenz in HIV-infected patients (ALIZE ANRS 099 trial).

    Published in:
    Journal of Antimicrobial Chemotherapy (JAC), 2011, v. 66, n. 1, p. 184, doi. 10.1093/jac/dkq395
    By:
    • Gallien, Sébastien;
    • Journot, Valérie;
    • Rozenbaum, Willy;
    • Yéni, Patrick;
    • Morlat, Philippe;
    • Poizot-Martin, Isabelle;
    • Reynes, Jacques;
    • Reliquet, Véronique;
    • Leclercq, Pascale;
    • Simon, François;
    • Chêne, Geneviève;
    • Molina, Jean-Michel
    Publication type:
    Article
    50